Free Trial

ASML (ASML) Financials

ASML logo
$1,442.92 +56.71 (+4.09%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$1,511.19 +68.27 (+4.73%)
As of 08:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for ASML

Annual Income Statements for ASML

This table shows ASML's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
1,507 1,639 2,483 2,966 2,897 4,341 6,659 6,017 8,672 7,837 11,278
Consolidated Net Income / (Loss)
1,507 1,639 2,483 2,966 2,897 4,341 6,659 6,017 8,672 7,837 11,278
Net Income / (Loss) Continuing Operations
1,507 1,639 2,483 2,966 2,876 4,341 6,659 6,017 8,672 7,837 11,278
Total Pre-Tax Income
1,683 1,885 2,870 3,361 3,021 4,907 7,589 6,907 10,048 9,360 13,386
Total Operating Income
1,701 1,850 2,931 3,394 3,049 4,949 7,640 6,954 10,003 9,339 13,263
Total Gross Profit
3,146 3,309 4,829 5,756 5,499 8,303 11,102 11,447 15,637 15,001 20,254
Total Revenue
6,832 7,233 10,766 12,526 13,265 17,076 21,064 22,651 30,485 29,255 38,338
Operating Revenue
6,832 7,233 10,766 12,526 13,265 17,076 21,064 22,651 30,485 29,255 38,338
Total Cost of Revenue
3,685 3,924 5,937 6,770 7,766 8,773 9,962 11,204 14,848 14,254 18,084
Operating Cost of Revenue
3,685 3,924 5,937 6,770 7,766 8,773 9,962 11,204 14,848 14,254 18,084
Total Operating Expenses
1,446 1,459 1,899 2,362 2,450 3,354 3,462 4,493 5,635 5,661 6,991
Selling, General & Admin Expense
376 394 500 559 584 666 821 1,012 1,231 1,207 1,476
Research & Development Expense
1,161 1,163 1,513 1,804 1,866 2,689 2,883 3,481 4,403 4,455 5,515
Total Other Income / (Expense), net
-18 35 -60 -32 -28 -43 -50 -48 46 20 123
Interest Expense
18 -35 60 32 - 43 50 48 -46 -20 -123
Income Tax Expense
175 247 368 402 145 674 1,156 1,038 1,588 1,740 2,363
Other Gains / (Losses), net
0.00 0.00 -20 7.10 - 108 225 148 212 217 254
Basic Earnings per Share
$3.22 $3.66 $4.81 $6.10 $6.13 $8.49 $14.36 $15.13 $22.02 $19.93 $29.02
Weighted Average Basic Shares Outstanding
430.60M 425.60M 429.80M 424.90M 420.80M 418.30M 409.80M 397.70M 393.80M 393.30M 388.50M
Diluted Earnings per Share
$3.21 $3.64 $4.79 $6.08 $6.12 $8.48 $14.34 $15.12 $22.00 $19.92 $29.00
Weighted Average Diluted Shares Outstanding
432.60M 427.70M 431.60M 426.40M 420.80M 419.10M 410.40M 398M 394.10M 393.60M 388.90M
Weighted Average Basic & Diluted Shares Outstanding
427.99M 429.94M 429.80M 424.90M 842.40M 418.30M 409.80M 394.59M 393.42M 393.28M 385.42M

Quarterly Income Statements for ASML

No quarterly income statements for ASML are available.


Annual Cash Flow Statements for ASML

This table details how cash moves in and out of ASML's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
43 472 -778 987 461 3,081 998 339 -276 5,926 247
Net Cash From Operating Activities
2,201 1,753 2,184 3,517 4,102 5,653 12,275 9,079 6,021 11,558 14,856
Net Cash From Continuing Operating Activities
2,201 1,753 2,184 3,517 7,253 5,653 12,275 9,079 6,021 11,558 14,856
Net Income / (Loss) Continuing Operations
1,507 1,639 2,483 2,966 2,897 4,341 6,659 6,017 8,672 7,837 11,278
Consolidated Net Income / (Loss)
1,507 1,639 2,483 2,966 2,897 4,341 6,659 6,017 8,672 7,837 11,278
Depreciation Expense
323 375 502 484 930 600 533 624 818 951 1,204
Non-Cash Adjustments To Reconcile Net Income
352 154 256 122 715 63 21 -174 732 794 958
Changes in Operating Assets and Liabilities, net
19 -415 -1,056 -55 2,712 649 5,062 2,612 -4,200 1,975 1,417
Net Cash From Investing Activities
-1,260 -3,354 -1,476 -563 -1,642 -1,652 -81 -1,101 -2,975 -2,701 -4,434
Net Cash From Continuing Investing Activities
-1,260 -3,354 -1,476 -563 -1,644 -1,652 -81 -1,101 -2,975 -2,701 -4,434
Purchase of Property, Plant & Equipment
-404 -333 -407 -657 -860 -1,175 -1,019 -1,371 -2,385 -2,140 -1,847
Acquisitions
-1.20 -2,787 -1,248 -41 - -320 -45 -40 -82 -16 -68
Purchase of Investments
-1,219 -2,667 -1,324 -1,054 -1,926 -1,802 -1,316 -358 -26 -861 -2,005
Sale and/or Maturity of Investments
364 2,441 1,502 1,184 1,144 1,660 2,067 925 139 316 6.22
Other Investing Activities, net
0.00 -7.78 1.20 5.04 -1.01 -15 -141 -257 -621 0.00 -520
Net Cash From Financing Activities
-906 2,066 -1,452 -1,973 -2,004 -920 -11,195 -7,637 -3,323 -2,932 -10,176
Net Cash From Continuing Financing Activities
-906 2,066 -1,452 -1,973 -2,004 -920 -11,195 -7,637 -3,323 -2,932 -10,176
Repayment of Debt
-3.91 -4.94 -292 -3.20 -86 -4.03 -14 -552 -833 -27 -1,252
Repurchase of Common Equity
-614 -421 -601 -1,312 -460 -1,475 -9,689 -4,964 -1,106 -518 -6,983
Payment of Dividends
-328 -469 -621 -683 -1,488 -1,303 -1,549 -2,738 -2,598 -2,539 -2,993
Issuance of Debt
0.00 2,347 - 0.00 0.00 1,816 0.00 530 1,104 23 885
Issuance of Common Equity
36 613 61 25 31 46 55 88 110 128 167
Cash Interest Paid
47 59 110 70 67 78 94 88 152 166 134
Cash Interest Received
- - - 43 44 39 41 45 211 175 236
Cash Income Taxes Paid
138 122 571 635 762 794 1,398 1,856 2,841 1,137 1,903

Quarterly Cash Flow Statements for ASML

No quarterly cash flow statements for ASML are available.


Annual Balance Sheets for ASML

This table presents ASML's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
14,446 18,101 21,849 23,047 25,396 35,264 34,215 38,834 44,201 50,295 59,345
Total Current Assets
8,375 9,002 10,674 12,053 13,614 19,261 20,588 24,675 26,985 31,816 35,931
Cash & Equivalents
2,672 3,058 2,714 3,572 3,964 7,390 7,868 7,776 7,749 13,183 15,158
Short-Term Investments
1,032 1,210 1,236 1,045 1,331 1,638 723 115 5.97 5.59 476
Note & Lease Receivable
305 471 71 699 634 2,235 1,342 1,451 1,526 85 1,032
Accounts Receivable
873 737 2,091 1,715 2,005 1,601 3,427 5,695 4,794 4,635 3,548
Inventories, net
2,796 2,926 3,550 3,937 4,275 5,582 5,862 7,702 9,791 11,274 13,413
Prepaid Expenses
531 590 613 884 946 - 1,132 1,758 1,746 2,008 1,682
Current Deferred & Refundable Income Taxes
165 12 74 91 201 82 48 36 1,108 294 104
Other Current Assets
- - 325 110 259 733 186 141 266 332 517
Plant, Property, & Equipment, net
1,761 1,775 1,923 1,819 2,244 3,018 3,376 4,220 6,077 7,087 9,264
Total Noncurrent Assets
4,310 7,323 9,252 9,174 9,538 12,985 10,252 9,940 11,140 11,392 14,150
Long-Term Investments
- 0.00 1,180 1,048 935 1,154 1,010 988 1,017 935 2,515
Noncurrent Note & Lease Receivables
135 123 191 315 606 489 574 390 1,095 1,836 1,957
Goodwill
2,852 5,127 5,455 5,197 5,096 5,681 5,156 4,874 5,076 4,750 5,385
Intangible Assets
802 1,392 1,401 1,264 1,239 3,242 1,078 901 820 643 634
Noncurrent Deferred & Refundable Income Taxes
32 37 38 270 500 986 1,244 1,790 2,071 2,009 2,018
Other Noncurrent Operating Assets
490 644 987 1,080 1,162 1,432 1,190 998 1,060 1,219 1,641
Total Liabilities & Shareholders' Equity
14,446 18,101 21,849 23,047 25,396 35,264 34,215 38,834 44,201 50,295 59,345
Total Liabilities
5,331 7,770 8,904 9,724 11,265 16,572 22,738 29,408 29,320 31,170 36,328
Total Current Liabilities
3,376 3,451 3,808 4,340 5,268 8,067 13,919 19,239 18,003 20,755 28,476
Short-Term Debt
4.58 261 30 0.00 0.00 43 576 798 0.11 1,046 1,974
Accounts Payable
574 624 1,006 1,103 1,192 1,683 2,395 2,744 2,597 3,623 4,133
Current Deferred & Payable Income Tax Liabilities
6.56 212 183 215 74 134 342 337 342 293 571
Other Current Liabilities
2,791 2,354 2,589 3,022 4,002 4,830 10,606 15,359 15,065 15,793 21,798
Total Noncurrent Liabilities
1,955 4,318 5,096 5,384 5,997 8,505 8,819 10,170 11,317 10,415 7,852
Long-Term Debt
1,223 3,232 3,604 3,464 3,488 5,696 4,612 3,759 5,123 3,806 3,179
Noncurrent Deferred & Payable Income Tax Liabilities
279 418 410 288 263 491 272 286 412 310 215
Other Noncurrent Operating Liabilities
450 648 1,083 1,632 2,245 2,318 3,935 6,124 5,782 6,298 4,458
Total Equity & Noncontrolling Interests
9,157 10,373 12,945 13,323 14,132 0.00 11,477 9,426 14,881 19,125 23,017
Total Preferred & Common Equity
9,157 10,373 12,945 13,323 14,132 18,692 11,477 9,426 14,881 19,125 23,017
Total Common Equity
9,115 10,331 12,945 13,323 14,132 0.00 11,477 9,426 14,881 19,125 23,017
Common Stock
3,378 3,927 4,530 4,326 4,276 - 4,428 4,255 4,463 4,228 4,861
Retained Earnings
5,742 6,609 8,783 10,527 10,688 - 9,414 9,678 13,694 14,920 20,640
Treasury Stock
-518 -838 -670 -1,856 -1,144 - -2,742 -4,965 -3,657 -493 -2,644
Accumulated Other Comprehensive Income / (Loss)
513 632 302 326 312 - 377 458 382 470 159

Quarterly Balance Sheets for ASML

This table presents ASML's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q4 2023 Q4 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets
38,834 44,201 50,295
Total Current Assets
24,675 26,985 31,816
Cash & Equivalents
7,776 7,749 13,183
Short-Term Investments
115 5.97 5.59
Note & Lease Receivable
1,451 1,526 85
Accounts Receivable
5,695 4,794 4,635
Inventories, net
7,702 9,791 11,274
Prepaid Expenses
1,758 1,746 2,008
Current Deferred & Refundable Income Taxes
36 1,108 294
Other Current Assets
141 266 332
Plant, Property, & Equipment, net
4,220 6,077 7,087
Total Noncurrent Assets
9,940 11,140 11,392
Long-Term Investments
988 1,017 935
Noncurrent Note & Lease Receivables
390 1,095 1,836
Goodwill
4,874 5,076 4,750
Intangible Assets
901 820 643
Noncurrent Deferred & Refundable Income Taxes
1,790 2,071 2,009
Other Noncurrent Operating Assets
998 1,060 1,219
Total Liabilities & Shareholders' Equity
38,834 44,201 50,295
Total Liabilities
29,408 29,320 31,170
Total Current Liabilities
19,239 18,003 20,755
Short-Term Debt
798 0.11 1,046
Accounts Payable
2,744 2,597 3,623
Current Deferred & Payable Income Tax Liabilities
337 342 293
Other Current Liabilities
15,359 15,065 15,793
Total Noncurrent Liabilities
10,170 11,317 10,415
Long-Term Debt
3,759 5,123 3,806
Noncurrent Deferred & Payable Income Tax Liabilities
286 412 310
Other Noncurrent Operating Liabilities
6,124 5,782 6,298
Total Equity & Noncontrolling Interests
9,426 14,881 19,125
Total Preferred & Common Equity
9,426 14,881 19,125
Total Common Equity
9,426 14,881 19,125
Common Stock
4,255 4,463 4,228
Retained Earnings
9,678 13,694 14,920
Treasury Stock
-4,965 -3,657 -493
Accumulated Other Comprehensive Income / (Loss)
458 382 470

Annual Metrics And Ratios for ASML

This table displays calculated financial ratios and metrics derived from ASML's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.59% 5.87% 48.86% 16.34% 5.90% 28.73% 23.35% 7.54% 34.58% -4.04% 31.05%
EBITDA Growth
8.80% 10.00% 54.23% 12.98% 1.54% 40.93% 47.29% -7.27% 42.78% -4.91% 40.59%
EBIT Growth
9.61% 8.78% 58.42% 15.80% -11.38% 64.55% 54.36% -8.97% 43.83% -6.63% 42.02%
NOPAT Growth
4.50% 5.56% 58.92% 16.91% -2.83% 47.08% 51.67% -8.75% 42.50% -9.71% 43.65%
Net Income Growth
4.10% 8.73% 51.49% 19.48% -2.34% 49.87% 53.38% -9.64% 44.12% -9.62% 43.90%
EPS Growth
18.01% 13.40% 31.59% 26.93% 0.66% 38.56% 69.10% 5.41% 45.55% -9.49% 45.62%
Operating Cash Flow Growth
77.42% -20.37% 24.63% 61.01% 16.64% 37.81% 117.14% -26.04% -33.68% 91.95% 28.53%
Free Cash Flow Firm Growth
73.58% -164.20% 150.53% 401.28% -20.54% -46.43% 868.06% -42.39% -70.86% 291.63% 19.75%
Invested Capital Growth
-7.20% 43.94% 19.82% -2.86% 2.42% 25.10% -50.42% -27.74% 120.05% -12.27% 1.68%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
46.06% 45.75% 44.85% 45.95% 41.46% 48.63% 52.71% 50.54% 51.29% 51.28% 52.83%
EBITDA Margin
29.61% 30.77% 31.88% 30.96% 29.68% 32.49% 38.80% 33.46% 35.50% 35.17% 37.74%
Operating Margin
24.89% 25.58% 27.22% 27.10% 22.98% 28.98% 36.27% 30.70% 32.81% 31.92% 34.60%
EBIT Margin
24.89% 25.58% 27.22% 27.10% 22.67% 28.98% 36.27% 30.70% 32.81% 31.92% 34.60%
Profit (Net Income) Margin
22.06% 22.66% 23.06% 23.68% 21.84% 25.42% 31.61% 26.56% 28.44% 26.79% 29.42%
Tax Burden Percent
89.58% 86.92% 86.49% 88.24% 95.89% 88.48% 87.74% 87.11% 86.30% 83.73% 84.25%
Interest Burden Percent
98.95% 101.92% 97.94% 99.05% 100.43% 99.14% 99.34% 99.31% 100.46% 100.22% 100.93%
Effective Tax Rate
10.42% 13.08% 12.81% 11.97% 4.79% 13.73% 15.23% 15.02% 15.81% 18.59% 17.65%
Return on Invested Capital (ROIC)
22.09% 19.86% 24.33% 26.47% 25.79% 33.31% 60.77% 97.12% 103.10% 72.12% 109.91%
ROIC Less NNEP Spread (ROIC-NNEP)
22.81% 18.01% 30.62% 27.63% 26.04% 34.55% 64.48% 94.67% 96.82% 68.50% 106.72%
Return on Net Nonoperating Assets (RNNOA)
-5.57% -3.08% -3.04% -3.89% -4.69% 28.13% 55.26% -39.56% -31.75% -26.02% -56.39%
Return on Equity (ROE)
16.52% 16.78% 21.29% 22.58% 21.10% 61.44% 116.03% 57.57% 71.35% 46.09% 53.52%
Cash Return on Invested Capital (CROIC)
29.56% -16.16% 6.30% 29.38% 23.40% 11.01% 128.19% 129.34% 28.08% 85.19% 108.24%
Operating Return on Assets (OROA)
11.64% 11.37% 14.67% 15.12% 12.42% 16.32% 21.99% 19.04% 24.09% 19.77% 24.19%
Return on Assets (ROA)
10.32% 10.07% 12.43% 13.21% 11.96% 14.31% 19.17% 16.47% 20.89% 16.59% 20.57%
Return on Common Equity (ROCE)
16.48% 16.71% 21.26% 22.58% 21.10% 61.44% 116.03% 57.57% 71.35% 46.09% 53.52%
Return on Equity Simple (ROE_SIMPLE)
16.46% 15.80% 19.18% 22.26% 20.50% 23.23% 58.02% 63.83% 58.27% 40.98% 0.00%
Net Operating Profit after Tax (NOPAT)
1,523 1,608 2,555 2,988 2,903 4,270 6,476 5,910 8,422 7,604 10,922
NOPAT Margin
22.30% 22.23% 23.73% 23.85% 21.88% 25.00% 30.74% 26.09% 27.62% 25.99% 28.49%
Net Nonoperating Expense Percent (NNEP)
-0.72% 1.85% -6.29% -1.16% -0.25% -1.24% -3.71% 2.45% 6.27% 3.62% 3.19%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 42.26% 42.10% 31.71% 38.77%
Cost of Revenue to Revenue
53.94% 54.25% 55.15% 54.05% 58.54% 51.37% 47.29% 49.46% 48.71% 48.72% 47.17%
SG&A Expenses to Revenue
5.50% 5.45% 4.65% 4.46% 4.40% 3.90% 3.90% 4.47% 4.04% 4.12% 3.85%
R&D to Revenue
16.99% 16.08% 14.05% 14.40% 14.07% 15.74% 13.69% 15.37% 14.44% 15.23% 14.38%
Operating Expenses to Revenue
21.16% 20.17% 17.63% 18.86% 18.47% 19.64% 16.44% 19.83% 18.48% 19.35% 18.23%
Earnings before Interest and Taxes (EBIT)
1,701 1,850 2,931 3,394 3,008 4,949 7,640 6,954 10,003 9,339 13,263
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,023 2,225 3,432 3,878 3,937 5,549 8,173 7,579 10,821 10,290 14,467
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.87 4.32 5.42 4.73 8.49 0.00 28.21 22.88 19.87 14.23 18.26
Price to Tangible Book Value (P/TBV)
6.46 11.72 11.53 9.18 15.38 0.00 61.75 59.06 32.91 19.81 24.72
Price to Revenue (P/Rev)
5.17 6.17 6.52 5.03 9.04 11.64 15.37 9.52 9.70 9.30 10.96
Price to Earnings (P/E)
23.42 27.25 28.27 21.24 41.41 45.80 48.62 35.84 34.10 34.72 37.26
Dividend Yield
0.93% 1.16% 0.80% 1.15% 1.23% 0.60% 0.51% 1.24% 0.86% 0.97% 0.69%
Earnings Yield
4.27% 3.67% 3.54% 4.71% 2.42% 2.18% 2.06% 2.79% 2.93% 2.88% 2.68%
Enterprise Value to Invested Capital (EV/IC)
4.94 4.59 6.00 5.47 10.29 13.64 45.21 41.39 26.00 26.67 40.64
Enterprise Value to Revenue (EV/Rev)
4.80 6.07 6.38 4.85 8.83 11.38 15.16 9.33 9.58 8.98 10.62
Enterprise Value to EBITDA (EV/EBITDA)
16.22 19.72 20.01 15.68 29.77 35.03 39.08 27.88 26.99 25.54 28.15
Enterprise Value to EBIT (EV/EBIT)
19.30 23.72 23.44 17.92 38.96 39.27 41.80 30.38 29.19 28.14 30.70
Enterprise Value to NOPAT (EV/NOPAT)
21.55 27.29 26.88 20.35 40.37 45.53 49.31 35.76 34.67 34.57 37.28
Enterprise Value to Operating Cash Flow (EV/OCF)
14.91 25.04 31.45 17.29 28.57 34.38 26.02 23.27 48.50 22.74 27.41
Enterprise Value to Free Cash Flow (EV/FCFF)
16.10 0.00 103.86 18.34 44.49 137.75 23.38 26.85 127.32 29.26 37.86
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.13 0.34 0.28 0.26 0.25 0.00 0.45 0.48 0.34 0.25 0.22
Long-Term Debt to Equity
0.13 0.31 0.28 0.26 0.25 0.00 0.40 0.40 0.34 0.20 0.14
Financial Leverage
-0.24 -0.17 -0.10 -0.14 -0.18 0.81 0.86 -0.42 -0.33 -0.38 -0.53
Leverage Ratio
1.60 1.67 1.71 1.71 1.76 4.29 6.05 3.49 3.42 2.78 2.60
Compound Leverage Factor
1.58 1.70 1.68 1.69 1.77 4.26 6.01 3.47 3.43 2.78 2.63
Debt to Total Capital
11.82% 25.19% 21.92% 20.63% 19.80% 100.00% 31.13% 32.59% 25.61% 20.24% 18.29%
Short-Term Debt to Total Capital
0.04% 1.88% 0.18% 0.00% 0.00% 0.75% 3.46% 5.71% 0.00% 4.36% 7.01%
Long-Term Debt to Total Capital
11.78% 23.31% 21.74% 20.63% 19.80% 99.25% 27.67% 26.89% 25.61% 15.87% 11.29%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
87.77% 74.51% 78.08% 79.37% 80.20% 0.00% 68.87% 67.41% 74.39% 79.76% 81.71%
Debt to EBITDA
0.61 1.57 1.06 0.89 0.89 1.03 0.63 0.60 0.47 0.47 0.36
Net Debt to EBITDA
-1.22 -0.35 -0.44 -0.57 -0.70 -0.80 -0.54 -0.57 -0.34 -0.90 -0.90
Long-Term Debt to EBITDA
0.60 1.45 1.05 0.89 0.89 1.03 0.56 0.50 0.47 0.37 0.22
Debt to NOPAT
0.81 2.17 1.42 1.16 1.20 1.34 0.80 0.77 0.61 0.64 0.47
Net Debt to NOPAT
-1.63 -0.48 -0.59 -0.74 -0.94 -1.04 -0.68 -0.73 -0.43 -1.22 -1.19
Long-Term Debt to NOPAT
0.80 2.01 1.41 1.16 1.20 1.33 0.71 0.64 0.61 0.50 0.29
Altman Z-Score
5.81 5.06 6.60 5.96 8.29 8.53 10.52 6.09 8.16 7.11 8.96
Noncontrolling Interest Sharing Ratio
0.23% 0.43% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.48 2.61 2.80 2.78 2.58 2.39 1.48 1.28 1.50 1.53 1.26
Quick Ratio
1.45 1.59 1.61 1.62 1.51 1.59 0.96 0.78 0.78 0.86 0.71
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
2,039 -1,309 661 3,315 2,634 1,411 13,660 7,870 2,293 8,982 10,756
Operating Cash Flow to CapEx
544.78% 526.68% 536.53% 535.31% 476.79% 481.04% 1,204.15% 662.10% 252.52% 540.16% 804.43%
Free Cash Flow to Firm to Interest Expense
113.71 0.00 10.95 102.36 0.00 33.10 270.62 164.94 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
122.76 0.00 36.15 108.58 0.00 132.60 243.18 190.29 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
100.22 0.00 29.41 88.29 0.00 105.03 222.98 161.55 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.47 0.44 0.54 0.56 0.55 0.56 0.61 0.62 0.73 0.62 0.70
Accounts Receivable Turnover
6.36 8.99 7.62 6.58 7.13 9.47 8.38 4.97 5.81 6.21 9.37
Inventory Turnover
1.25 1.37 1.83 1.81 1.89 1.78 1.74 1.65 1.70 1.35 1.47
Fixed Asset Turnover
3.89 4.09 5.82 6.69 6.53 6.49 6.59 5.96 5.92 4.44 4.69
Accounts Payable Turnover
6.28 6.55 7.29 6.42 6.77 6.10 4.88 4.36 5.56 4.58 4.66
Days Sales Outstanding (DSO)
57.35 40.62 47.92 55.44 51.18 38.54 43.56 73.50 62.80 58.82 38.95
Days Inventory Outstanding (DIO)
291.27 266.14 199.06 201.84 192.97 205.05 209.64 220.94 215.01 269.69 249.13
Days Payable Outstanding (DPO)
58.14 55.70 50.10 56.86 53.94 59.82 74.72 83.71 65.65 79.63 78.27
Cash Conversion Cycle (CCC)
290.48 251.06 196.88 200.42 190.21 183.77 178.49 210.72 212.16 248.88 209.81
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
6,639 9,555 11,449 11,122 11,390 14,249 7,065 5,105 11,233 9,854 10,020
Invested Capital Turnover
0.99 0.89 1.03 1.11 1.18 1.33 1.98 3.72 3.73 2.77 3.86
Increase / (Decrease) in Invested Capital
-515 2,917 1,894 -328 269 2,859 -7,184 -1,960 6,128 -1,378 166
Enterprise Value (EV)
32,820 43,881 68,693 60,809 117,196 194,381 319,360 211,304 292,014 262,821 407,208
Market Capitalization
35,297 44,657 70,188 63,011 119,938 198,824 323,773 215,625 295,663 272,092 420,204
Book Value per Share
$21.05 $24.14 $30.11 $31.17 $33.56 $0.00 $27.56 $23.70 $37.71 $48.61 $58.52
Tangible Book Value per Share
$12.61 $8.91 $14.16 $16.06 $18.51 ($21.25) $12.59 $9.18 $22.77 $34.91 $43.22
Total Capital
10,384 13,865 16,579 16,787 17,620 5,739 16,665 13,984 20,005 23,977 28,170
Total Debt
1,227 3,492 3,634 3,464 3,488 5,739 5,188 4,558 5,123 4,852 5,153
Total Long-Term Debt
1,223 3,232 3,604 3,464 3,488 5,696 4,612 3,759 5,123 3,806 3,179
Net Debt
-2,476 -776 -1,496 -2,202 -2,741 -4,443 -4,413 -4,321 -3,648 -9,271 -12,997
Capital Expenditures (CapEx)
404 333 407 657 860 1,175 1,019 1,371 2,385 2,140 1,847
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,300 1,544 2,946 3,096 3,051 2,209 -1,346 -1,657 1,227 -1,082 -6,206
Debt-free Net Working Capital (DFNWC)
5,003 5,812 6,896 7,713 8,346 11,237 7,245 6,234 8,982 12,107 9,429
Net Working Capital (NWC)
4,999 5,551 6,866 7,713 8,346 11,194 6,669 5,436 8,981 11,061 7,455
Net Nonoperating Expense (NNE)
16 -31 73 21 6.29 -71 -183 -107 -250 -234 -356
Net Nonoperating Obligations (NNO)
-2,518 -817 -1,496 -2,202 -2,741 14,249 -4,413 -4,321 -3,648 -9,271 -12,997
Total Depreciation and Amortization (D&A)
323 375 502 484 930 600 533 624 818 951 1,204
Debt-free, Cash-free Net Working Capital to Revenue
19.02% 21.35% 27.37% 24.72% 23.00% 12.94% -6.39% -7.31% 4.02% -3.70% -16.19%
Debt-free Net Working Capital to Revenue
73.24% 80.36% 64.05% 61.58% 62.92% 65.81% 34.40% 27.52% 29.46% 41.38% 24.59%
Net Working Capital to Revenue
73.17% 76.75% 63.77% 61.58% 62.92% 65.55% 31.66% 24.00% 29.46% 37.81% 19.45%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.22 $3.46 $4.93 $6.10 $6.16 $8.49 $0.00 $14.14 $19.91 $19.93 $29.02
Adjusted Weighted Average Basic Shares Outstanding
430.64M 425.60M 429.80M 424.90M 420.80M 418.30M 0.00 397.70M 393.80M 393.30M 388.50M
Adjusted Diluted Earnings per Share
$3.21 $3.44 $4.91 $6.08 $6.15 $8.48 $0.00 $14.13 $19.89 $19.92 $29.00
Adjusted Weighted Average Diluted Shares Outstanding
432.64M 427.68M 431.60M 426.40M 421.60M 419.10M 0.00 398M 394.10M 393.60M 388.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
427.99M 429.94M 427.39M 421.10M 419.81M 416.51M 0.00 394.59M 393.42M 393.28M 385.42M
Normalized Net Operating Profit after Tax (NOPAT)
1,523 1,608 2,555 2,988 2,903 4,270 6,476 5,910 8,422 7,604 10,922
Normalized NOPAT Margin
22.30% 22.23% 23.73% 23.85% 21.88% 25.00% 30.74% 26.09% 27.62% 25.99% 28.49%
Pre Tax Income Margin
24.63% 26.07% 26.66% 26.84% 22.77% 28.73% 36.03% 30.49% 32.96% 31.99% 34.92%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
94.85 0.00 48.50 104.78 0.00 116.09 151.35 145.76 0.00 0.00 0.00
NOPAT to Interest Expense
84.97 0.00 42.29 92.24 0.00 100.15 128.29 123.86 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
72.32 0.00 41.77 84.50 0.00 88.52 131.15 117.02 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
62.44 0.00 35.55 71.95 0.00 72.58 108.10 95.12 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
21.79% 28.62% 25.00% 23.04% 51.36% 30.01% 23.26% 45.51% 29.96% 32.40% 26.54%
Augmented Payout Ratio
62.51% 54.30% 49.19% 67.27% 67.25% 63.99% 168.76% 128.01% 42.71% 39.00% 88.46%

Quarterly Metrics And Ratios for ASML

No quarterly metrics and ratios for ASML are available.



Financials Breakdown Chart

Key Financial Trends

Here are the top balance sheet trends for ASML (NASDAQ: ASML) drawn from the last three reported years (2022–2024). The bullets are ordered with positives first, then neutral, then negatives.

  • Cash & Equivalents jumped to US$13,182,930,090 in FY2024, up from US$7,748,599,140 in FY2023 and US$7,775,627,340 in FY2022, boosting liquidity and financial flexibility.
  • Total equity rose to US$19,125,335,680 in FY2024, up from US$14,881,044,880 in FY2023 and US$9,425,793,840 in FY2022, reflecting stronger retained earnings and a stronger balance sheet.
  • Total assets expanded to US$50,295,094,960 in FY2024, up from US$44,200,986,500 in FY2023 and US$38,834,167,920 in FY2022, indicating scale growth.
  • Accounts receivable declined to US$4,634,660,250 in FY2024 from US$4,794,381,420 in FY2023 and US$5,695,401,240 in FY2022, suggesting improved collections or timing.
  • Inventories, net rose to US$11,273,791,650 in FY2024 from US$9,790,644,340 in FY2023 and US$7,702,239,060 in FY2022, signaling higher production or stock buildup.
  • Goodwill decreased to US$4,749,659,860 in FY2024 from US$5,075,909,320 in FY2023 (and US$4,873,580,880 in FY2022), a shift that could reflect impairment or disposals.
  • Current liabilities climbed to US$20,755,204,140 in FY2024 from US$18,003,073,140 in FY2023 and US$19,238,855,280 in FY2022, driven by higher short-term payables and other current liabilities.
  • Short-term debt remained elevated at US$1,045,761,530 in FY2024 (up from US$798,284,760 in FY2022), indicating higher near-term leverage.
  • Long-term debt edged up to US$3,806,373,230 in FY2023 (and remained at that level in FY2024) from US$3,759,491,160 in FY2022, contributing to higher overall leverage.
  • Total liabilities increased to US$31,169,759,280 in FY2024 from US$29,408,374,080 in FY2022, signaling higher leverage despite an expanding equity base.
05/06/26 08:18 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About ASML's Financials

When does ASML's fiscal year end?

According to the most recent income statement we have on file, ASML's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

How has ASML's net income changed over the last 10 years?

ASML's net income appears to be on an upward trend, with a most recent value of $11.28 billion in 2025, rising from $1.51 billion in 2015. The previous period was $7.84 billion in 2024. View ASML's forecast to see where analysts expect ASML to go next.

What is ASML's operating income?
ASML's total operating income in 2025 was $13.26 billion, based on the following breakdown:
  • Total Gross Profit: $20.25 billion
  • Total Operating Expenses: $6.99 billion
How has ASML's revenue changed over the last 10 years?

Over the last 10 years, ASML's total revenue changed from $6.83 billion in 2015 to $38.34 billion in 2025, a change of 461.2%.

How much debt does ASML have?

ASML's total liabilities were at $36.33 billion at the end of 2025, a 16.5% increase from 2024, and a 581.5% increase since 2015.

How much cash does ASML have?

In the past 10 years, ASML's cash and equivalents has ranged from $2.67 billion in 2015 to $15.16 billion in 2025, and is currently $15.16 billion as of their latest financial filing in 2025.

How has ASML's book value per share changed over the last 10 years?

Over the last 10 years, ASML's book value per share changed from 21.05 in 2015 to 58.52 in 2025, a change of 178.0%.



Financial statements for NASDAQ:ASML last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners